Publicaciones en las que colabora con VISITACIÓN GALLARDO LARA (22)

2012

  1. Doxorubicin-loaded nanoparticles: New advances in breast cancer therapy

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 12, Núm. 9, pp. 1058-1070

  2. Drug delivery to inflammation based on nanoparticles surface decorated with biomolecules

    Current Medicinal Chemistry, Vol. 19, Núm. 19, pp. 3203-3211

  3. Maghemite/poly(D,L-lactide-co-glycolyde) composite nanoplatform for therapeutic applications

    Journal of Nanoparticle Research, Vol. 14, Núm. 4

  4. Potenciación de la actividad antitumoral de doxorrubicina mediante su formulación en nanoplataformas magnéticas

    Anales de la Real Academia Nacional de Farmacia, Núm. 3, pp. 344-370

2011

  1. Lipid-based drug delivery systems for cancer treatment

    Current Drug Targets, Vol. 12, Núm. 8, pp. 1151-1165

  2. Multifunctional antitumor magnetite/chitosan-L-glutamic acid (core/shell) nanocomposites

    Journal of Nanoparticle Research, Vol. 13, Núm. 9, pp. 4311-4323

2010

  1. Basic engineering processes for drug loading to polymeric carriers

    Handbook of Drug Targeting and Monitoring: Developments, Challenges and Applications (Nova Science Publishers, Inc.), pp. 513-523

  2. Chitosan nanoparticles as a new delivery system for the chemotherapy agent tegafur

    Drug Development and Industrial Pharmacy, Vol. 36, Núm. 6, pp. 744-750

  3. Medicines made with olive oil

    Olive Oil and Health (Nova Science Publishers, Inc.), pp. 589-598

  4. Skin Creams Made with Olive Oil

    Olives and Olive Oil in Health and Disease Prevention (Elsevier Inc.), pp. 1133-1141

2009

  1. El futuro farmacéutico y el botiquín familiar: aprendiendo a realizar educación sanitaria

    Ars pharmaceutica, Vol. 50, Núm. 3, pp. 118-123

  2. Study of the stability of Kollidon® SR suspensions for pharmaceutical applications

    Colloids and Surfaces A: Physicochemical and Engineering Aspects, Vol. 338, Núm. 1-3, pp. 107-113

2008

  1. Determinación de la estabilidad de Kollicoat MAE 30D mediante medidas de calorimetría diferencial de barrido

    Ars pharmaceutica, Vol. 49, Núm. 1, pp. 67-76

  2. Magnetic colloids as drug vehicles

    Journal of Pharmaceutical Sciences, Vol. 97, Núm. 8, pp. 2948-2983

  3. Magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-Fluorouracil delivery systems for active targeting

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 69, Núm. 1, pp. 54-63

  4. Study of carbonyl iron/poly(butylcyanoacrylate) (core/shell) particles as anticancer drug delivery systems. Loading and release properties

    European Journal of Pharmaceutical Sciences, Vol. 33, Núm. 3, pp. 252-261

  5. Tegafur loading and release properties of magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles

    Journal of Controlled Release, Vol. 125, Núm. 1, pp. 50-58

2007

  1. Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres

    International Journal of Pharmaceutics, Vol. 337, Núm. 1-2, pp. 282-290

2006

  1. Colloidal stability of magnetite/poly(lactic acid) core/shell nanoparticles

    Langmuir, Vol. 22, Núm. 6, pp. 2816-2821

  2. Preparation and characterization of carbonyl iron/poly(butylcyanoacrylate) core/shell nanoparticles

    Journal of Colloid and Interface Science, Vol. 299, Núm. 2, pp. 599-607